Super-response to sacubitril valsartan: prevalence and clinical profile

被引：0
|
作者：
Moliner Abos, C. [1 ]
Rivas-Lasarte, M. [2 ]
Pamies Besora, J. [1 ]
Fluvia Brugues, P. [1 ]
Sole-Gonzalez, E. [1 ]
Mirabet, S. [1 ]
Lopez Lopez, L. [1 ]
Brossa, V. [1 ]
Mesado, N. [1 ]
Pirla, M. J. [1 ]
Roig, E. [2 ]
Alvarez-Garcia, J. [2 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, CIBERCV, Cardiol, IIb St Pau, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1174
引用
收藏
页码：290 / 291
页数：2
相关论文
共 50 条
  • [21] Sacubitril/valsartan in real-life clinical practice
    Cavusoglu, Yuksel
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2021, 49 (05): : 353 - 356
  • [22] Sacubitril/Valsartan in clinical practice, how does it work?
    Backelin, C. Nordberg
    Pivodic, A.
    Fu, M.
    Ljungman, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 426 - 426
  • [23] Metabolic effects of sacubitril/valsartan: are they relevant in clinical practice?
    de la Espriella-Juan, Rafael
    Sanchis, Juan
    Bayes-Genis, Antoni
    Nunez, Julio
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2018, 8 (04) : 549 - 551
  • [24] Sacubitril/Valsartan in Clinical Practice: A Report of 2 Cases
    Cosentino, Eugenio
    CARDIOLOGY, 2017, 138 : 7 - 10
  • [25] Clinical and gated SPECT MPI parameters associated with super-response to cardiac resynchronization therapy
    Mesquita, Claudio T.
    Peix, Amalia
    de Amorim Fernandes, Fernando
    Giubbini, Raffaele
    Karthikeyan, Ganesan
    Massardo, Teresa
    Patel, Chetan
    Pabon, Luz M.
    Jimenez-Heffernan, Amelia
    Alexanderson, Erick
    Butt, Sadaf
    Kumar, Alka
    Marin, Victor
    Morozova, Olga
    Paez, Diana
    Garcia, Ernest V.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (03) : 1166 - 1174
  • [26] Incidence and predictors of super-response to cardiac resynchronization therapy
    Rohit, Manoj Kumar
    Krishnappa, Darshan
    INDIAN HEART JOURNAL, 2019, 71 (04) : 334 - 337
  • [27] FACTORS ASSOCIATED WITH SUPER-RESPONSE TO CARDIAC RESYNCHRONISATION THERAPY
    Soldatova, Anna
    Kuznetsov, Vadim
    Krinochkin, Dmitrii
    Enina, Tatyana
    Pavlov, Alexandr
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C144 - C144
  • [28] Putative predictors of super-response to CGRP monoclonal antibodies
    Pinheiro, A. R.
    Rego, A.
    Neves, P.
    Delgado, S.
    Dionisio, J.
    Madureira, B.
    Costa, J.
    Carapinha, D.
    Abreu, A.
    Saraiva, M.
    Parreira, E.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [29] Predictors and Outcomes of "Super-response" to Cardiac Resynchronization Therapy
    Killu, Ammar M.
    Grupper, Avishay
    Friedman, Paul A.
    Powell, Brian D.
    Asirvatham, Samuel J.
    Espinosa, Raul E.
    Luria, David
    Rozen, Guy
    Buber, Jonathan
    Lee, Ying-Hsiang
    Webster, Tracy
    Brooke, Kelly L.
    Hodge, David O.
    Wiste, Heather J.
    Glikson, Michael
    Cha, Yong-Mei
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (06) : 379 - 386
  • [30] Clinical Profile of a Nonselected Population Treated With Sacubitril/Valsartan Is Different From PARADIGM-HF Trial
    Vicent, Lourdes
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    De-Juan, Javier
    Diez-Villanueva, Pablo
    Manuel Iniesta, Angel
    Ayesta, Ana
    Gonzalez-Saldivar, Hugo
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Perea-Egido, Jesus A.
    Martinez-Selles, Manuel
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (02) : 112 - 116
12345